Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
In the last decade, a plethora of immunotherapeutic strategies have been designed to modulate the tumor immune microenvironment. In particular, immune checkpoint (IC) blockade therapies present the most promising advances made in cancer treatment in recent years. In non-small cell lung cancer (NSCLC...
Main Authors: | Assia Hijazi, Carlotta Antoniotti, Chiara Cremolini, Jérôme Galon |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2243169 |
Similar Items
-
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancerResearch in context
by: François Ghiringhelli, et al.
Published: (2023-06-01) -
The consensus immunoscore: toward a new classification of colorectal cancer
by: Anastasia Lanzi, et al.
Published: (2020-01-01) -
Immunoscore Guided Cold Tumors to Acquire “Temperature” Through Integrating Physicochemical and Biological Methods
by: Jing Liu, et al.
Published: (2020-06-01) -
Principles of risk assessment in colon cancer: immunity is key
by: Assia Hijazi, et al.
Published: (2024-12-01) -
Usefulness and robustness of Immunoscore for personalized management of cancer patients
by: Florence Marliot, et al.
Published: (2020-01-01)